Capricor Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update
7 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
Velocity
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
The brief
"Capricor Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update" is generating significant coverage in the Business category, with 8 articles from 7 distinct sources tracked by PULSE so far.
Outlets currently covering the story include Benzinga, KVUE, Devdiscourse and Fierce Biotech. PULSE measures a story's velocity from how quickly new articles appear and how many independent newsrooms join the coverage.
This brief was generated by PULSE's extractive engine from coverage metadata only. The latest headlines from every source are listed below; the velocity chart shows how the story is developing in real time.
Generated by PULSE's extractive engine from coverage metadata only — no AI-written claims. Updated 44d ago.
Quick answers
Why is "Capricor Therapeutics Reports Second Quarter 2026 Financial Results and Provides" trending?
Because 7 independent news sources published 8 articles about it in a short window — a coverage burst PULSE classifies as a trend.
How does PULSE measure this trend?
PULSE scores velocity from the rate of new articles weighted by source diversity, snapshotted hourly. The full method is public on our methodology page.
Is this trend still active?
The status badge on this page updates hourly: rising, peaking, cooling, or archived once coverage stops for 48 hours.
Coverage (8)
- Why Is Capricor Therapeutics Stock Soaring Today? Benzinga · 47d ago
- Capricor: Q2 Earnings Snapshot KVUE · 47d ago
- Capricor's Stock Surge, Congo's Ebola Outbreak, and More in Health News Devdiscourse · 47d ago
- This Capricor Therapeutics Analyst Turns Bullish; Here Are Top 5 Upgrades For Friday Benzinga · 47d ago
- Capricor soars on plan to amend DMD filing after adcomm setback Fierce Biotech · 47d ago
- Capricor shares soar as potential FDA lifeline revives Duchenne drug hopes Reuters · 47d ago
- CAPR Stock Explodes Premarket: Cantor Flips Bullish, Sees 278% Upside On Deramiocel FDA Path Yahoo Finance · 47d ago
- Capricor Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update Capricor Therapeutics, Inc. · 47d ago
Topics
Related trends
Beam Therapeutics sues Chinese biotech, VC-backed startup, alleging theft of intellectual property
5 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
Caleb Williams' hamstring injury recovery timetable revealed: Reports
3 news sources are covering this Sports story right now — PULSE is tracking how fast it spreads.
Costco Reports Higher Fourth-Quarter Profit, Revenue on Resilient Consumer Spending
Costco reports higher fourth-quarter profit and revenue as resilient consumer spending drives performance.
Costco Wholesale Corporation Reports Fourth Quarter and Fiscal Year 2026 Operating Results
Costco reports strong fourth-quarter and fiscal year 2026 operating results, beating estimates amid inflation and tariff refunds.
All-WNBA First and Second Teams: SB Nation’s official picks
2 news sources are covering this Sports story right now — PULSE is tracking how fast it spreads.
Fantasy playbook: NFL Week 3 Shadow Reports, lineup locks and projected scores
3 news sources are covering this Sports story right now — PULSE is tracking how fast it spreads.